When the Board met in March 2025, the Cost Management, Benefit Design and Administration Committee (CMBDA) made a recommendation for the Board to issue a statement to provide guidance to Administering Authorities on the 2025 Actuarial Valuation process following on from the previous surplus statement and Funding Strategy Statement (FSS) guidance issued by the Board.

The statement approved by the Board is available here.